IP Library Granted Patent US 11,091,742
Granted Patent B2
US 11,091,742 · App. 16/229,084 · Granted Aug 17, 2021

Directed evolution of CYP52A12 gene and its use in dicarboxylic acid production

Inventors: Wenbo Liu (Shanghai, CN); Min Xu (Shanghai, CN); Howard Chou (Shanghai, CN); Xiucai Liu (Shanghai, CN)
Assignees: CATHAY BIOTECH INC.; CIBT AMERICA INC.
C12N9/0071C12N15/52C12N9/001C12P7/6409C12Y114/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,091,742
App. No.
16/229,084
Granted
Aug 17, 2021
Kind
B2
Abstract

The invention relates to the directed evolution of CYP52A12 gene and the use thereof for the production of a dicarboxylic acid. In particular, it relates to a method of preparing a long chain dicarboxylic acid producing strain by using directed evolution and homologous recombination, a strain obtained by the method that is capable of producing a long chain dicarboxylic acid under an acidic condition and the use thereof. In particular, the invention relates to a method of preparing a long chain dicarboxylic acid producing strain by directed evolution of CYP52A12 gene and homologous recombination, a strain obtained by the method that is capable of producing a long chain dicarboxylic acid under an acidic condition and the use thereof. By directed evolution of CYP52A12 gene, one strain which has a base mutation at the promoter region of said gene and is capable of producing a long chain dicarboxylic acid under an acidic condition in a shortened fermentation time is screened out in the invention.

Claims (2)

1. A product comprising an isolated modified CYP52A12 protein, wherein, with reference to the amino acid numbering of SEQ ID NO:20, the modified CYP52A12 protein comprises Asp at a position corresponding to the position 76 of SEQ ID NO: 20 and Ile at a position corresponding to the position 470 of SEQ ID NO: 20, compared to an unmodified CYP52A12 protein, and wherein the modified CYP52A12 protein comprises an amino acid sequence at least 99% identical to SEQ ID NO. 20 and has the capability of producing a long chain dicarboxylic acid under an acidic culture condition that is at least 95% or more of that of the modified CYP52A12 protein comprising the amino acid sequence set forth in SEQ ID NO.21.

2. The product of claim 1 , wherein the modified CYP52A12 protein comprises the amino acid sequence set forth in SEQ ID NO:21.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2019
From: SHANGHAI CATHAY BIOTECH R& D CENTER, LTD
To: CATHAY BIOTECH INC.
Reel/Frame 050328/0934 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2019
From: CATHAY INDUSTRIAL BIOTECH LTD.
To: CIBT AMERICA INC.
Reel/Frame 050329/0008 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2019
From: LIU, WENBO; XU, MIN; CHOU, HOWARD; LIU, XIUCAI
To: SHANGHAI CATHAY BIOTECH R&D CENTER LTD.; CATHAY INDUSTRIAL BIOTECH LTD.
Reel/Frame 048144/0354 →
Priority Claims (2)
CN 201810299532.8 · Apr 4, 2018 · national
CN 201811433497.0 · Nov 28, 2018 · national
Continuity (2)
Related Publication 20190309270A1 · Oct 10, 2019
Related Publication 20210180032A9 · Jun 17, 2021